Summary

for people ages 18 years and up (full criteria)
at San Francisco, California
study started
estimated completion
Encouse B Golden

Description

Summary

This trial studies how well Uber health intervention works in eliminating transportation barriers for disadvantaged patients with cancer that has spread to nearby tissue, lymph nodes, or other places in the body, undergoing ambulatory palliative radiotherapy. Uber health intervention provides free transportation to disadvantaged patients and may reduce the amount of missed radiotherapy appointments, patient anxiety, and the amount of unplanned emergency department visits, as well as improve quality of life.

Details

PRIMARY OBJECTIVES:

  1. To test whether eliminating transportation barriers for disadvantaged cancer patients can reduce the 6-month rate of unplanned emergency department (ED) visits.

SECONDARY OBJECTIVES:

  1. To test whether eliminating transportation barriers for disadvantaged cancer patients for the duration of a palliative radiotherapy course will improve prescribed treatment completion rates and reduce treatment delays and overall time to treatment completion.

II. To test whether eliminating transportation barriers for disadvantaged cancer patients for the duration of a palliative radiotherapy course will have an impact on physician choice for therapeutic modality, (3-dimensional conformal radiation therapy [3D CRT] versus intensity-modulated radiation therapy [IMRT] versus stereotactic body radiation therapy [SBRT]) and the fractionation schedules to minimize patient inconvenience.

III. To test whether eliminating transportation barriers for disadvantaged cancer patients for the duration of a palliative radiotherapy course can reduce the short-term (6- months) rate of grade >= 3 radiation related adverse events as measured by the Common Terminology Criteria for Adverse Events (CTCAE) version 5.

IV. To test whether eliminating transportation barriers for disadvantaged cancer patients for the duration of a palliative radiotherapy course can improve the patient?s experience, functional outcome, and overall quality of life as measured by the European Organization for Research and Treatment of Cancer [EORTC] quality of life questionnaire [QLQ]30.

  1. To test whether eliminating transportation barriers for disadvantaged cancer patients for the duration of a palliative radiotherapy course can reduce re-treatment rates, improve the progression free survival rates, and overall survival.

VI. To determine if living within San Francisco County versus the surrounding counties (Alameda, Contra Costa, Marin, San Mateo) within the San Francisco Bay Area has an impact on outcomes.

OUTLINE:

Patients receive Uber rides to and from scheduled radiotherapy appointments for up to 6 months.

After completion of study, patients are followed up every 3 months for up to 3 years.

Keywords

Locally Advanced Malignant Neoplasm Metastatic Malignant Neoplasm Neoplasms Neoplasms, Second Primary Quality-of-Life Assessment Supportive Care Heath services research (Uber rides)

Eligibility

You can join if…

Open to people ages 18 years and up

  • Written informed consent (and assent when applicable) obtained from patient or patient?s legal representative and ability for patient to comply with the requirements of the study
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • Histologically confirmed locally advanced or metastatic cancer
  • Patients who have received prior courses of radiotherapy are eligible
  • If patient answers yes to >= 2/4 of the questions below:
  • In the last six months, have you ever had to go without health care because you didn?t have a way to get there?
  • Do you put off or neglect going to the doctor because of distance or transportation?
  • Does lack of money for transportation expenses (parking, taxi, bus) make it difficult to get to the doctor?
  • Would it be difficult to find a friend or relative to take you to a doctor?s appointment, if you could not drive/transport yourself?

You CAN'T join if...

  • Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
  • Patients who are living at a facility such as a nursing home or skilled nursing facility
  • Patients who do not live within a 30-mile radius of one of the radiation oncology sites at University of California San Francisco (UCSF)
  • Patients who are currently receiving or expected to be receive UCSF affiliated transportation services prior to enrollment onto the study
  • Patients who are wheel-chair bound or require special assistance in order to under radiation treatment ineligible

Location

  • University of California, San Francisco not yet accepting patients
    San Francisco California 94115 United States

Lead Scientist

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT03849742
Study Type
Interventional
Last Updated